Insights from the ESDR 2022 ADVENT symposium, uncovering the role of type 2 inflammation in skin barrier and neuroimmune dysfunction in atopic dermatitis.
Skin barrier dysfunction and neuroimmune dysfunction are hallmarks of atopic dermatitis, that are driven in part by type 2 inflammation. In this ADVENT-sponsored symposium at the ESDR Congress in Amsterdam, experts Laurent Misery, MD, PhD (University Hospital of Brest, France), Lisa A. Beck, MD (University of Rochester, USA), and Simon G. Danby, PhD (University of Sheffield, UK), examined the ways in which type 2 inflammation impacts and influences the skin barrier in atopic dermatitis.